Welcome to Endpoints News’ manufacturing briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
Catalent is reducing its headcount by 130 employees at its facility in Bloomington, IN, across current and open roles, a company spokesperson told Endpoints. This is to focus on “increasing efficiencies and reducing costs across our business,” the company added. The site is one of three facilities Novo Nordisk is set to absorb on the back of Novo Holding’s announced acquisition of Catalent.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.